836 related articles for article (PubMed ID: 27987130)
1. Ultrasound image features of intravesical prostatic protrusion indicated failure of medication therapy of finasteride and doxazosin in patients with benign prostatic hyperplasia (LUTS/BPH).
Liu Q; Zhu Y; Liu J; Qi J; Kang J
Int Urol Nephrol; 2017 Mar; 49(3):399-404. PubMed ID: 27987130
[TBL] [Abstract][Full Text] [Related]
2. Combination therapy with doxazosin and finasteride for benign prostatic hyperplasia in patients with lower urinary tract symptoms and a baseline total prostate volume of 25 ml or greater.
Kaplan SA; McConnell JD; Roehrborn CG; Meehan AG; Lee MW; Noble WR; Kusek JW; Nyberg LM;
J Urol; 2006 Jan; 175(1):217-20; discussion 220-1. PubMed ID: 16406915
[TBL] [Abstract][Full Text] [Related]
3. [Clinical impact of the intravesical prostatic protrusion: a review by the LUTS committee of the French Urological Association].
Lebdai S; Ammi M; Bigot P; Cornu JN; Mathieu R; Descazeaud A; Azzouzi AR;
Prog Urol; 2014 Apr; 24(5):313-8. PubMed ID: 24674338
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of resistive index of the prostate and bladder sonomorphologic parameters as replacements for urodynamics to predict bladder outlet obstruction in patients with lower urinary tract symptoms suggestive of benign prostatic hyperplasia.
Garg G; Sankhwar SN; Goel A; Pandey S; Sharma D; Parihar A
Low Urin Tract Symptoms; 2019 May; 11(3):163-168. PubMed ID: 30793849
[TBL] [Abstract][Full Text] [Related]
5. [Correlation of serum prostate specific antigen, the volume and the intravesical prostatic protrusion for diagnosing bladder outlet obstruction in patients with benign prostate hyperplasia].
Bantis A; Zissimopoulos A; Kalaytzis C; Giannakopoulos S; Sountoulides P; Agelonidou E; Voudalikakis C; Touloupidis S
Hell J Nucl Med; 2007; 10(2):138-43. PubMed ID: 17684595
[TBL] [Abstract][Full Text] [Related]
6. [The relationship between intravesical prostatic protrusion and pressure flow study findings in patients with benign prostate obstruction/lower urinary tract symptoms].
Park SC; Lee JW; Rim JS
Actas Urol Esp; 2012 Mar; 36(3):165-70. PubMed ID: 22018947
[TBL] [Abstract][Full Text] [Related]
7. [Ultrasound indicators of the prostate, urinary bladder and uroflowmetry parameters in the diagnosis of infravesical obstruction in men with benign prostatic hyperplasia].
Krivoborodov GG; Efremov NS; Bolotov AD
Urologiia; 2017 Oct; (5):9-14. PubMed ID: 29135135
[TBL] [Abstract][Full Text] [Related]
8. Intravesical prostatic protrusion can predict therapeutic response to silodosin in male patients with lower urinary tract symptoms.
Matsukawa Y; Ishida S; Majima T; Funahashi Y; Sassa N; Kato M; Yoshino Y; Gotoh M
Int J Urol; 2017 Jun; 24(6):454-459. PubMed ID: 28370376
[TBL] [Abstract][Full Text] [Related]
9. Adding Cyclooxygenase-2 inhibitor to alpha blocker for patients with benign prostate hyperplasia and elevated serum prostate specific antigen could not improve prostate biopsy detection rate but improve lower urinary tract symptoms.
Jhang JF; Jiang YH; Kuo HC
Int J Clin Pract; 2013 Dec; 67(12):1327-33. PubMed ID: 24246211
[TBL] [Abstract][Full Text] [Related]
10. Intravesical prostatic protrusion can be a predicting factor for the treatment outcome in patients with lower urinary tract symptoms due to benign prostatic obstruction treated with tamsulosin.
Cumpanas AA; Botoca M; Minciu R; Bucuras V
Urology; 2013 Apr; 81(4):859-63. PubMed ID: 23375910
[TBL] [Abstract][Full Text] [Related]
11. Finasteride for benign prostatic hyperplasia.
Tacklind J; Fink HA; Macdonald R; Rutks I; Wilt TJ
Cochrane Database Syst Rev; 2010 Oct; 2010(10):CD006015. PubMed ID: 20927745
[TBL] [Abstract][Full Text] [Related]
12. Intravescical prostatic protrusion is a predictor of alpha blockers response: results from an observational study.
Topazio L; Perugia C; De Nunzio C; Gaziev G; Iacovelli V; Bianchi D; Vespasiani G; Finazzi Agrò E
BMC Urol; 2018 Feb; 18(1):6. PubMed ID: 29394926
[TBL] [Abstract][Full Text] [Related]
13. Long-term treatment with finasteride results in a clinically significant reduction in total prostate volume compared to placebo over the full range of baseline prostate sizes in men enrolled in the MTOPS trial.
Kaplan SA; Roehrborn CG; McConnell JD; Meehan AG; Surynawanshi S; Lee JY; Rotonda J; Kusek JW; Nyberg LM;
J Urol; 2008 Sep; 180(3):1030-2; discussion 1032-3. PubMed ID: 18639298
[TBL] [Abstract][Full Text] [Related]
14. Three-Year Treatment Outcomes of Water Vapor Thermal Therapy Compared to Doxazosin, Finasteride and Combination Drug Therapy in Men with Benign Prostatic Hyperplasia: Cohort Data from the MTOPS Trial.
Gupta N; Rogers T; Holland B; Helo S; Dynda D; McVary KT
J Urol; 2018 Aug; 200(2):405-413. PubMed ID: 29499208
[TBL] [Abstract][Full Text] [Related]
15. Association between metabolic syndrome and intravesical prostatic protrusion in patients with benign prostatic enlargement and lower urinary tract symptoms (MIPS Study).
Russo GI; Regis F; Spatafora P; Frizzi J; Urzì D; Cimino S; Serni S; Carini M; Gacci M; Morgia G
BJU Int; 2018 May; 121(5):799-804. PubMed ID: 28872764
[TBL] [Abstract][Full Text] [Related]
16. Monotherapy versus combination drug therapy for the treatment of benign prostatic hyperplasia.
Logan YT; Belgeri MT
Am J Geriatr Pharmacother; 2005 Jun; 3(2):103-14. PubMed ID: 16129387
[TBL] [Abstract][Full Text] [Related]
17. Dutasteride add-on therapy reduces detrusor mass in patients with benign prostatic enlargement not satisfied with alpha-adrenergic antagonist monotherapy: A single center prospective study.
De Nunzio C; Brassetti A; Proietti F; Gacci M; Serni S; Esperto F; Tubaro A
Neurourol Urodyn; 2017 Nov; 36(8):2096-2100. PubMed ID: 28257560
[TBL] [Abstract][Full Text] [Related]
18. The role of combination medical therapy in benign prostatic hyperplasia.
Greco KA; McVary KT
Int J Impot Res; 2008 Dec; 20 Suppl 3():S33-43. PubMed ID: 19002123
[TBL] [Abstract][Full Text] [Related]
19. Clinical significance of intravesical prostatic protrusion in patients with benign prostatic enlargement.
Keqin Z; Zhishun X; Jing Z; Haixin W; Dongqing Z; Benkang S
Urology; 2007 Dec; 70(6):1096-9. PubMed ID: 18158025
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of Intravesical Prostatic Protrusion as a Predictor of Dutasteride-Resistant Lower Urinary Tract Symptoms/Benign Prostatic Enlargement With a High Likelihood of Surgical Intervention.
Hirayama K; Masui K; Hamada A; Shichiri Y; Masuzawa N; Hamada S
Urology; 2015 Sep; 86(3):565-9. PubMed ID: 26199172
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
